- Article
Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication
- Gabriel Antherieu,
- Audrey Bidet,
- Sarah Huet,
- Sandrine Hayette,
- Marina Migeon,
- Lisa Boureau,
- Pierre Sujobert,
- Xavier Thomas,
- Hervé Ghesquières and
- Arnaud Pigneux
- + 1 author
Recently, a new subset of acute myeloid leukemia (AML) presenting a direct partial tandem duplication (PTD) of the KMT2A gene was described. The consequences of this alteration in terms of outcome and response to treatment remain unclear. We analyzed...

